Carol F. Kwiatkowski

Dr. Carol F. Kwiatkowski

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Environmental Science & Technology Letters
Verified
Journal Article
Closed access
CKCarol F. Kwiatkowski
Carol F. Kwiatkowski
DADavid Q. Andrews
David Q. Andrews
LBLinda S. Birnbaum
Linda S. Birnbaum
TBThomas A. Bruton
Thomas A. Bruton
JDJamie C. DeWitt
Jamie C. DeWitt
ABArlene Blum
Arlene Blum

9 May 2023 in Environmental Science & Technology
Verified
Journal Article
Open access
WAWilliam A. Arnold
William A. Arnold
ABArlene Blum
Arlene Blum
JBJennifer Branyan
Jennifer Branyan
TBThomas A. Bruton
Thomas A. Bruton
CCCourtney C. Carignan
Courtney C. Carignan
GZGuomao Zheng
Guomao Zheng
Quaternary ammonium compounds (QACs), a large class of chemicals that includes high production volume substances, have been used for decades as antimicrobials, preservatives, and antistatic agents and for other functions in cleaning, disinfecting, personal care products, and durable consumer goods. QAC use has accelerated in response to the COVID-19 pandemic and the banning of 19 antimicrobials from several personal care products by the US Food and Drug Administration in 2016. Studies conducted before and after the onset of the pandemic indicate increased human exposure to QACs. Environmental releases of these chemicals have also increased. Emerging information on adverse environmental and human health impacts of QACs is motivating a reconsideration of the risks and benefits across the life cycle of their production, use, and disposal. This work presents a critical review of the literature and scientific perspective developed by a multidisciplinary, multi-institutional team of authors from academia, governmental, and nonprofit organizations. The review evaluates currently available information on the ecological and human health profile of QACs and identifies multiple areas of potential concern. Adverse ecological effects include acute and chronic toxicity to susceptible aquatic organisms, with concentrations of some QACs approaching levels of concern. Suspected or known adverse health outcomes include dermal and respiratory effects, developmental and reproductive toxicity, disruption of metabolic function such as lipid homeostasis, and impairment of mitochondrial function. QACs' role in antimicrobial resistance has also been demonstrated. In the US regulatory system, how a QAC is managed depends on how it is used, for example in pesticides or personal care products. This can result in the same QACs receiving different degrees of scrutiny depending on the use and the agency regulating it. Further, the US Environmental Protection Agency's current method of grouping QACs based on structure, first proposed in 1988, is insufficient to address the wide range of QAC chemistries, potential toxicities, and exposure scenarios. Consequently, exposures to common mixtures of QACs and from multiple sources remain largely unassessed. Some restrictions on the use of QACs have been implemented in the US and elsewhere, primarily focused on personal care products. Assessing the risks posed by QACs is hampered by their vast structural diversity and a lack of quantitative data on exposure and toxicity for the majority of these compounds. This review identifies important data gaps and provides research and policy recommendations for preserving the utility of QAC chemistries while also seeking to limit adverse environmental and human health effects.

19 January 2023 in Environmental Science & Technology
Verified
Journal Article
Open access
SBSimona A. Bǎlan
Simona A. Bǎlan
DADavid Q. Andrews
David Q. Andrews
ABArlene Blum
Arlene Blum
MDMiriam L. Diamond
Miriam L. Diamond
SFSeth Rojello Fernández
Seth Rojello Fernández
CKCarol F. Kwiatkowski
Carol F. Kwiatkowski
Chemicals have improved the functionality and convenience of industrial and consumer products, but sometimes at the expense of human or ecological health. Existing regulatory systems have proven to be inadequate for assessing and managing the tens of thousands of chemicals in commerce. A different approach is urgently needed to minimize ongoing production, use, and exposures to hazardous chemicals. The premise of the essential-use approach is that chemicals of concern should be used only in cases in which their function in specific products is necessary for health, safety, or the functioning of society and when feasible alternatives are unavailable. To optimize the essential-use approach for broader implementation in the United States and Canada, we recommend that governments and businesses (1) identify chemicals of concern for essentiality assessments based on a broad range of hazard traits, going beyond toxicity; (2) expedite decision-making by avoiding unnecessary assessments and strategically asking up to three questions to determine whether the use of the chemical in the product is essential; (3) apply the essential-use approach as early as possible in the process of developing and assessing chemicals; and (4) engage diverse experts in identifying chemical uses and functions, assessing alternatives, and making essentiality determinations and share such information broadly. If optimized and expanded into regulatory systems in the United States and Canada, other policymaking bodies, and businesses, the essential-use approach can improve chemicals management and shift the market toward safer chemistries that benefit human and ecological health.

1 July 2002 in Journal of Drug Issues
Verified
Journal Article
Closed access
PDF file
KCKaren Fortuin Corsi
Karen Fortuin Corsi
CKCarol F. Kwiatkowski
Carol F. Kwiatkowski
RBRobert E. Booth
Robert E. Booth
This study was conducted to assess behavior change in the areas of drug use, productivity, criminal activity, and HIV risk among street-recruited injection drug users who entered methadone maintenance treatment. In addition, the study examined a number of variables that could account for these changes, including demographics, intervention effects, and treatment-related measures. A total of 168 participants were interviewed at baseline, received outreach interventions, entered methadone maintenance treatment, and were reinterviewed 5–9 months later. Significant (p<.001) improvements were seen in the areas of drug use, productivity, criminality, and HIV risk behaviors. The only variables significantly associated with behavior change were related to drug treatment. In particular, being in treatment at the time of the follow-up assessment had the strongest relationship to positive outcomes, including length of treatment. Having no prior treatment experience was associated with fewer injections at follow-up. These findings emphasize the importance of retaining clients, given the likelihood that positive change is likely to be evidenced while they remain in treatment

1 February 2021 in Environmental Science & Technology Letters
Verified
Journal Article
Closed access
CKCarol F. Kwiatkowski
Carol F. Kwiatkowski
DADavid Q. Andrews
David Q. Andrews
LBLinda S. Birnbaum
Linda S. Birnbaum
TBThomas A. Bruton
Thomas A. Bruton
JDJamie C. DeWitt
Jamie C. DeWitt
ABArlene Blum
Arlene Blum

4 October 2006 in Health Services and Outcomes Research Methodology
Verified
Journal Article
Closed access
PDF file
KCKaren F. Corsi
Karen F. Corsi
BHBenjamin Van Hunnik
Benjamin Van Hunnik
CKCarol F. Kwiatkowski
Carol F. Kwiatkowski
RBRobert E. Booth
Robert E. Booth